ストックスクリーナーアプリを入手
65.28
3.57%
2.25
アフターアワーズ：
65.28
Bio Techne Corp (TECH) 最新ニュース
Maryland Representative April McClain Delaney Purchased as Much as $135,000 in Bio-Techne Shares - Bitget
Bio-Techne (NASDAQ:TECH) Cut to Hold at Evercore ISI - MarketBeat
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
TECH: Evercore ISI Downgrades Bio-Techne's Rating and Lowers Pri - GuruFocus
Should Bio-Techne’s (TECH) Revenue Miss Raise Doubts About Its Scientific Platform’s Commercial Potential? - simplywall.st
Bio-Techne Corp (NASDAQ:TECH) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Fort Washington Investment Advisors Inc. OH Buys 35,165 Shares of Bio-Techne Corp $TECH - MarketBeat
Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH) - Yahoo Finance
Bio-Techne Corp (TECH) Stock Price History & Data - Traders Union
Voya Investment Management LLC Has $7.04 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Assenagon Asset Management S.A. Invests $2.75 Million in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference - Investing News Network
Bio-Techne (TECH): Revisiting Valuation as Recent Gains Contrast a Weak One-Year Shareholder Return - Yahoo Finance
Bio-Techne Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Riverbridge Partners LLC Trims Stock Position in Bio-Techne Corp $TECH - MarketBeat
Will Bio Techne Corporation stock gain from strong economyMarket Rally & Free Low Drawdown Momentum Trade Ideas - Улправда
Why Bio Techne Corporation stock appeals to analystsJuly 2025 Momentum & Capital Protection Trade Alerts - Улправда
Will New 3D Multiomic Workflow and Leo System Expansion Change Bio-Techne's (TECH) Narrative? - simplywall.st
How Bio Techne Corporation stock compares to industry benchmarksJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - DonanımHaber
Bio-Techne (NASDAQ:TECH) Downgraded to Strong Sell Rating by Zacks Research - MarketBeat
Trading Action: Will Bio Techne Corporation stock gain from strong economyMarket Volume Summary & Technical Pattern Based Buy Signals - Улправда
Thrivent Financial for Lutherans Has $11.53 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Corient Private Wealth LLC Reduces Stake in Bio-Techne Corp $TECH - MarketBeat
Aaron Wealth Advisors LLC Takes $980,000 Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector? - Barchart.com
Neuberger Berman Group LLC Has $128.62 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Reassessing Bio-Techne (TECH) Valuation After a Weak Year and Recent Share Price Rebound - simplywall.st
Bamco Inc. NY Has $143.81 Million Stake in Bio-Techne Corp $TECH - MarketBeat
4D Advisors LLC Makes New $2.06 Million Investment in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
GMP Cytokine Market and Competition Outlook to 2031: Growing at 8.4% CAGR, Led by Bio-Techne, PeproTech, CellGenix Among OthersResearchAndMarkets.com - The AI Journal
Osterweis Capital Management Inc. Has $7.70 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Cerity Partners LLC Boosts Stake in Bio-Techne Corp $TECH - MarketBeat
Check out Bio-Techne Corp's stock price (1TECH-IT) in real time - CNBC
Here’s Why BioTechne (TECH) Traded Lower in Q3 - Yahoo Finance
Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology - Investing News Network
Bio-techne and Wyss Center partner to develop automated 3D multiomics - Investing.com
Bio-Techne (NASDAQ: TECH) and Wyss Geneva to develop automated 3D multiomics workflow - Stock Titan
Amundi Buys 19,844 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Stake Lessened by SVB Wealth LLC - MarketBeat
Bio-Techne Corp (NASDAQ:TECH) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Does Bio-Techne’s Recent Weakness Offer an Opportunity After Its Cell and Gene Therapy Push? - Yahoo Finance
Bio-Techne Announces Expanded Launch Of Next-Generation Leo System - Nasdaq
Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis - Investing News Network
Bio-techne ships enhanced Leo System with expanded detection capabilities - Investing.com
Bio-Techne (NASDAQ: TECH) debuts Leo system with dual-channel fluorescence - Stock Titan
Transcript : Bio-Techne Corporation Presents at 53rd Annual Nasdaq Investor Conference, Dec-09-2025 09 - marketscreener.com
Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch
WINTON GROUP Ltd Makes New $6.23 Million Investment in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Invesco Ltd. - MarketBeat
Arrowstreet Capital Limited Partnership Has $18.94 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Quantbot Technologies LP Purchases New Stake in Bio-Techne Corp $TECH - MarketBeat
Baird Financial Group Inc. Has $29.11 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Cresset Asset Management LLC Boosts Holdings in Bio-Techne Corp $TECH - MarketBeat
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):